It was first approved for the treatment of type 2 diabetes as a once-weekly injection (0.5 mg, 1 mg, or 2 mg) in 2017 (Ozempic) and as a once-daily oral pill (7 mg or 14 mg) in 2019 (Rybelsus)
Are there any serious health risks associated with using Semaglutide
Even if medication is not currently a viable option, whether because of cost or conflicting factors, you can continue your weight loss journey
Honestly, patient education is huge - most people don't realize these meds take weeks to work and give up too soon
Non-pharmacological interventions include: Structured diabetes self-management education programmes (such as DESMOND or X-PERT) addressing foot care, injury prevention, and self-monitoring Podiatry services for nail care, callus management, and orthotic provision Physiotherapy to address gait abnormalities and reduce fall risk Psychological support for chronic pain management Foot protection is paramount for patients with sensory loss
In the biggest trial, people on the highest dose lost an average of 71 pounds (28.7% of their body weight) over about 16 months